Axsome Therapeutics is a New York-based pharmaceutical company dedicated to developing innovative treatments for central nervous system (CNS) conditions, including depression, Alzheimer's disease agitation, migraine, narcolepsy, and fibromyalgia.
With a strong focus on improving the lives of patients, Axsome is committed to turning patient needs into breakthrough discoveries through the development of products such as AXS-05, AXS-07, AXS-12, and AXS-14.
Generated from the website